Here’s a great graph - made by the talented @andrewpannu, which describes the current #GeneEditing landscape by charting 42 public & private #CRISPR companies - each with its clinical pipeline & the modality it uses. #BioTech#CRISPR#Genomics $CRSP $NTLA $BEAM $CRBU $VERV $PRME
I had a great visit today - fascinating conversations and hopefully future collaborations. Thanks so much for inviting me @dbetel and @ElementoLab ! The baby slept peacefully through my whole talk (whew) and we got to see Macy’s getting set up for the parade on our way home.
Hi! I am again posting videos from the lectures in my #Immunology course on YouTube this semester. Here is the link to the Fall 2022 playlist:
https://t.co/NvUtwMRsjM
Videos from Lectures 1 and 7 need editing and will be available eventually, today's lecture (11) is on the way!
DNA nanostructures: Through, rather than across, a News & Views article from Marcel P. Bruchez
https://t.co/4VfE6E9qvS (free view)
https://t.co/cFIxw9oXHe (£)
We're sad to report the passing of our dear colleague and friend, Marcel Bruchez. He was a brilliant scientist, an entrepreneur and innovator, and a beloved teacher and mentor. He will be deeply missed. https://t.co/kqDYlQrJD7
Richard Feynman's Lectures on Physics are timeless: their main strength is in demonstrating how to reason about physics. You may not know all the lectures are completely online:
Volume 1: https://t.co/yDpyRViG61
Volume 2: https://t.co/oEctaDhy2X
Volume 3: https://t.co/eXS03nu9fE
I am sure we have not used public scRNAseq data enough:
1. https://t.co/Sqj7IrZGwl
2. https://t.co/XpdJJX3Hs6
3. https://t.co/qFTmQmTKTQ
described in recent 3 science papers. people can find creative ways to use the data and make papers out of them.